PRIMARY STUDY

Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study

Key Findings:  The synthetic pharmaceutical cannabinoid or THC analogue i.e. nabilone significantly reduces levodopa-induced dyskinesia in patients with Parkinson's Disease.

Type of Study:  Double Blind Clinical Trial

Study Sample Size:  7

Study Result:  Positive

Research Location(s):  United Kingdom

Year of Pub:  2001


Cannabinoids Studied:  Pharma THC

Phytocannabinoid Source:  Not Applicable

Chemotype:  Chemotype I

Sub-Ratio: 1:0

Route of Administration:  Oral (Ingestion)




Citation:  Sieradzan KA, et al. Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. Neurology. 2001; 57:2108-11. doi: 10.1212/wnl.57.11.2108

Authors:  Sieradzan KA, Fox SH, Hill M, Dick JP, Crossman AR, Brotchie JM